Liver Cancer
📧 Sign up to get email alerts when something new happens for Liver Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone [NA]
Completed clinical trial evaluating nutritional support for patients operated for hepatobiliary neoplasms.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: PRIORITY-CONNECT 2 Pilot Trial [NA]
The PRIORITY-CONNECT 2 Pilot Trial is currently recruiting. Sponsored by the Surgical Outcomes Research Centre, the study investigates liver…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection [Phase 3]
Phase 3 trial assessing the effect of smoked plum and chewing gum on postoperative bowel function after hepatic resection for liver cancer h…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Ultrasound Monitoring of Abdominal Soft Tissue [NA]
Clinical trial update for ultrasound monitoring in pancreatic and liver cancers; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Ablation Confirmation Study [NA]
A clinical trial update for an ablation confirmation study sponsored by Ethicon, terminated with results posted in 2024. The study related t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating sorafenib tosylate after liver transplant for hepatocellular carcinoma and related liver cancers has compl…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, and pharmacodynamics of H3B-6527 in advanced hepatocellular carcinoma; trial completed wit…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action [Phase 4]
A Phase 4 clinical trial investigates how using different anesthetics affects prognosis in primary tumors and explores the mechanism of acti…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer [Phase 2]
A Phase 2 clinical trial update for SB-715992 in locally advanced, recurrent, or metastatic liver cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating transarterial chemoembolization combined with nivolumab for intermediate-stage hepatocellular carcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation [NA]
A completed feasibility study on 3D perfusion ultrasound for planning and evaluating response to SBRT in liver cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC [Phase 1, Phase 2]
Phase Ib/II trial investigating INC280 plus PDR001 or PDR001 alone in advanced hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures [Phase 4]
Phase 4 clinical trial updating comparison of hepatic hilar nerve block versus sham for pain control during liver ablation and transarterial…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]
Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial [Phase 3]
A Phase 3 randomized controlled trial evaluating the applicability of 3D-HDRA in patients with primary liver cancer that is resectable.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers [Phase 1, Phase 2]
Clinical trial update on a combination therapy (Cryoablation + dendritic cell/cytokine-induced killer cells) for advanced liver cancers, spa…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy [Phase 2]
Phase 2 trial evaluating erlotinib plus bevacizumab as second-line therapy for hepatocellular carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/II trial evaluating safety and efficacy of QL1706 in patients with advanced hepatocellular carcinoma is ongoing and status is unkno…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A clinical trial update for T3011 administered intravenously in patients with advanced solid tumors, including various cancer types, spannin…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial [Phase 3]
Phase 3 clinical trial update for the HeLiX trial evaluating tranexamic acid to reduce hemorrhage during liver resection.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
-
CLINICAL_TRIALS withdrawal · 2022-04-01Clinical Trial Update: Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases [Phase 2, Phase 3]
A study evaluating anti-CEA CAR-T plus chemotherapy versus chemotherapy alone in pancreatic cancer with liver metastases has been withdrawn …
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 study comparing MLN0128 to sorafenib in advanced or metastatic hepatocellular carcinoma was terminated with results posted.